Printer friendly view

Financial Overview

Tecan supplies laboratories in the life sciences sector with laboratory instruments and comprehensive automation solutions.

The demand for the Company's products is supported by several megatrends.With the aging population, the incidence of diseases such as cancer, diabetes, cardiovascular diseases increases which stimulates research and development of novel drugs. Also, the volume for routine diagnostic tests is growing and new specialized tests are being introduced.In Emerging Markets, more people have increased access to healthcare and major investments in healthcare and life science research take place.

With the Life Sciences Business (end-customer business) and the Partnering Business (OEM business), Tecan can count on two strong pillars for accelerated profitable growth.

Key financial highlights

  • Solid operating margin with potential for further margin improvement
  • Low capital expenditures (CAPEX) and net working capital to sales
    translating into strong cash flows
  • High return on net assets (RONA)
  • Low tax rate
  • Strong balance sheet with high equity ratio and net liquidity position
    (cash and cash equivalents less bank liabilities and loans)

For an overview of the 2014 key figures and the five-year consolidated data, please follow the links to the left.

Contact Information

T +41 44 922 8430

Half Year Results 2015

Maennedorf, Switzerland
August 12, 2015
10:00 AM (CET)
Presentation (PDF)